83 FR 48865 - Certain Dental Ceramics, Products Thereof, and Methods of Making the Same; Commission Decision To Review in Part a Final Initial Determination Finding No Violation of Section 337; Schedule for Filing Written Submissions on the Issues Under Review and on Remedy, the Public Interest, and Bonding; Extension of the Target Date
INTERNATIONAL TRADE COMMISSION Federal Register Volume 83, Issue 188 (September 27, 2018)
Federal Register Volume 83, Issue 188 (September 27, 2018)
| Page Range | 48865-48867 | |
| FR Document | 2018-21007 |
[Federal Register Volume 83, Number 188 (Thursday, September 27, 2018)] [Notices] [Pages 48865-48867] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-21007] ----------------------------------------------------------------------- INTERNATIONAL TRADE COMMISSION [Investigation No. 337-TA-1050] Certain Dental Ceramics, Products Thereof, and Methods of Making the Same; Commission Decision To Review in Part a Final Initial Determination Finding No Violation of Section 337; Schedule for Filing Written Submissions on the Issues Under Review and on Remedy, the Public Interest, and Bonding; Extension of the Target Date AGENCY: U.S. International Trade Commission. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: Notice is hereby given that the U.S. International Trade Commission has determined to review in part the final initial determination (``final ID'') issued by the presiding administrative law judge (``ALJ'') on July 23, 2018, finding no violation of section 337 of the Tariff Act of 1930, in the above-captioned investigation. The Commission requests certain briefing from the parties on the issues under review, as indicated in this notice. The Commission also requests briefing from the parties, interested persons, and interested government agencies on the issues of remedy, the public interest, and bonding. The Commission has determined to extend the target date for completion of the investigation from November 23, 2018 to November 30, 2018. FOR FURTHER INFORMATION CONTACT: Sidney A. Rosenzweig, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 708-2532. Copies of non- confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205-2000. General information concerning the Commission may also be obtained by accessing its internet server at https://www.usitc.gov. The public record for this investigation may be viewed on the Commission's electronic docket (EDIS) at https://edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission TDD terminal on (202) 205- 1810. SUPPLEMENTARY INFORMATION: The Commission instituted this investigation on April 25, 2017, based on a complaint, as supplemented, filed by Ivoclar Vivadent AG of Schaan, Liechtenstein; Ivoclar Vivadent, Inc. of Amherst, New York; and Ardent, Inc. of Amherst, New York (collectively ``Ivoclar''). 82 FR 19081 (Apr. 25, 2017). The complaint, as supplemented, alleged violations of section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), in the importation into the United States, the sale for importation, or the sale within the United States after importation of certain dental ceramics, products thereof, and methods of making the same by reason of the infringement of certain claims of four United States patents: U.S. Patent No. 7,452,836 (``the '836 patent''); U.S. Patent No. 6,517,623 (``the '623 patent''); U.S. Patent No. 6,802,894 (``the '894 patent''); and U.S. Patent No. 6,455,451 (``the '451 patent''). The notice of investigation named as respondents GC Corporation of Tokyo, Japan; and GC America, Inc. of Alsip, Illinois (collectively, ``GC''). The Office of Unfair Import Investigations was also named as a party. The investigation was previously terminated as to certain asserted patent claims, including all of the asserted claims of the '623 patent and the '451 patent, based upon withdrawal of the complaint. Order No. 18 (Nov. 21, 2017), not reviewed, Notice (Dec. 6, 2017); Order No. 24 (Dec. 19, 2017), not reviewed, Notice (Jan. 18, 2018); Order No. 51 (Feb. 22, 2018), not reviewed, Notice (Mar. 23, 2018); Order No. 56 (Mar. 28, 2018), not reviewed, Notice (Apr. 27, 2018). Remaining within the scope of the investigation, as to infringement, domestic industry, or both, are claims 1, 2, 4, 5, 7, 9, 10, 13, 15-19, and 21 of the '836 patent; and claims 1, 2, 4, 16-21, 34, 36 and 38 of the '894 patent. On July 23, 2018, the ALJ issued the final ID. The ID finds, inter alia, that Ivoclar failed to demonstrate infringement of the above- referenced claims of the '836 patent. The ID finds, inter alia, that claims 36 and 38 (``the '894 flexure strength claims'') are invalid as indefinite under 35 U.S.C. 112 ] 2. The ID further finds that Ivoclar failed to demonstrate infringement and failed to meet the technical prong of the domestic industry requirement as to the remaining claims of the '894 patent (claims 1, 2, 4, 5, 7, 9, 10, 13, 15-19, and 21) (``the '894 annealing claims''). The ID finds that some, but not all, of the '894 annealing claims are invalid in view of certain prior art. Ivoclar, GC, and the Commission investigative attorney filed petitions for review and replies to the other parties' petitions. Having reviewed the record of the investigation, including the final ID, as well as the parties' petitions for review and responses thereto, the Commission has determined as follows. The Commission has determined to review the ID's findings as to the '894 annealing claims. The Commission has determined not to review the ID's findings as to the '894 flexure strength claims because the Commission finds that the invalidity of claims 36 and 38 has been shown clearly and convincingly. The Commission has determined not to review the ID's findings for the '836 patent claims. Accordingly, the Commission finds no violation of section 337 as to the '836 patent and as to the '894 flexure strength claims. The Commission has determined not to review the remainder of the ID. In connection with the Commission's review, the Commission notes that ``[a]ny issue not raised in a petition for review will be deemed to have been abandoned by the petitioning party and may be disregarded by the Commission in reviewing the initial determination.'' 19 CFR 210.43(b)(2). The parties are asked to provide additional briefing on the following issues, with reference to the applicable law and the existing evidentiary record. For each argument presented, the parties' submissions should set forth whether and/or how that argument was presented and preserved in the proceedings before the ALJ, in conformity with the ALJ's Ground Rules (Order No. 2), with citations to the record. 1. For purposes of invalidity of the '894 annealing claims, if the Commission were to find that a person of ordinary skill is entitled to rely upon the patentee's representation about the [[Page 48866]] disclosure of Barrett teaching lithium disilicates, see, e.g., PharmaStem Therapeutics, Inc. v. Viacell, Inc., 491 F.3d 1342, 1362 (Fed. Cir. 2007) (``Admissions in the specification regarding the prior art are binding on the patentee for purposes of a later inquiry into obviousness.''), what is the role, if any, of enablement of the prior art, see, e.g., Hoeschst Marion Roussel, Inc., 314 F.3d 1313, 1354 (Fed. Cir. 2003) (``A claimed invention cannot be anticipated by a prior art reference if the allegedly anticipatory disclosures cited as prior art are not enabled.'')? Please be certain to identify the appropriate burdens of production and persuasion, and the effect of those burdens in this investigation. 2. If the Commission finds that the sequence of steps performed by GC can practice the ``annealing'' limitation of the '894 annealing claims if annealing were to occur: a. Whether Ivoclar demonstrated, by a preponderance of evidence, that GC's methods practice the ``annealing'' limitation of claim 1 of the '894 patent (including all time and temperature limitations). b. Whether the WO196 patent application (RX-563) can be invalidating prior art, as discussed in Ivoclar's reply to GC's petition, at p. 94. c. Whether, to ascertain if GC's products or Ivoclar's products meet the other limitations of claim 1, or the limitations of any claim dependent upon claim 1, a remand to the presiding ALJ is warranted. In connection with the final disposition of this investigation, the Commission may (1) issue an order that could result in the exclusion of the subject articles from entry into the United States, and/or (2) issue one or more cease and desist orders that could result in the respondent(s) being required to cease and desist from engaging in unfair acts in the importation and sale of such articles. Accordingly, the Commission is interested in receiving written submissions that address the form of remedy, if any, that should be ordered. If a party seeks exclusion of an article from entry into the United States for purposes other than entry for consumption, the party should so indicate and provide information establishing that activities involving other types of entry either are adversely affecting it or likely to do so. For background, see Certain Devices for Connecting Computers via Telephone Lines, Inv. No. 337-TA-360, USITC Pub. No. 2843, Comm'n Op. (December 1994). If the Commission contemplates some form of remedy, it must consider the effects of that remedy upon the public interest. The factors the Commission will consider include the effect that an exclusion order and/or cease and desist orders would have on (1) the public health and welfare, (2) competitive conditions in the U.S. economy, (3) U.S. production of articles that are like or directly competitive with those that are subject to investigation, and (4) U.S. consumers. The Commission is therefore interested in receiving written submissions that address the aforementioned public interest factors in the context of this investigation. If the Commission orders some form of remedy, the U.S. Trade Representative, as delegated by the President, has 60 days to approve or disapprove the Commission's action. See Presidential Memorandum of July 21, 2005, 70 FR 43251 (July 26, 2005). During this period, the subject articles would be entitled to enter the United States under bond, in an amount determined by the Commission. The Commission is therefore interested in receiving submissions concerning the amount of the bond that should be imposed if a remedy is ordered. Written Submissions: The parties to the investigation are requested to file combined written submissions on the issues under review and remedy, the public interest and bonding. Interested government agencies, and any other interested parties are encouraged to file written submissions on the issues of remedy, the public interest, and bonding. Such submissions should address the recommended determination by the ALJ on remedy and bonding. The parties' submissions on the issues under review and on remedy, the public interest, and bonding should not exceed 40 pages. Reply submissions on the issues under review should not exceed 25 pages per side. Parties are encouraged to incorporate by reference any arguments adequately presented in their petitions for review and responses thereto, rather than repeating arguments. The page limits above are exclusive of exhibits, but parties are not to circumvent the page limits by incorporating material by reference from the exhibits or from the record. The complainants' opening submission is to include proposed remedial orders for the Commission's consideration; the date that the '894 patent expires; the HTSUS numbers under which the accused products are imported; and the names of known importers of the products at issue in this investigation. Written submissions by the parties and the public must be filed no later than close of business on Friday, October 5, 2018. Reply submissions by the parties and the public must be filed no later than the close of business on Friday, October 12, 2018. No further submissions will be permitted unless otherwise ordered by the Commission. Persons filing written submissions must file the original document electronically on or before the deadlines stated above and submit 8 true paper copies to the Office of the Secretary by noon the next day pursuant to section 210.4(f) of the Commission's Rules of Practice and Procedure (19 CFR 210.4(f)). Submissions should refer to the investigation number (``Inv. No. 337-TA-1050'') in a prominent place on the cover page and/or the first page. (See Handbook for Electronic Filing Procedures, https://www.usitc.gov/secretary/fed_reg_notices/rules/handbook_on_electronic_filing.pdf). Persons with questions regarding filing should contact the Secretary (202-205-2000). Any person desiring to submit a document to the Commission in confidence must request confidential treatment. All such requests should be directed to the Secretary to the Commission and must include a full statement of the reasons why the Commission should grant such treatment. See 19 CFR 201.6. Documents for which confidential treatment by the Commission is properly sought will be treated accordingly. All information, including confidential business information and documents for which confidential treatment is properly sought, submitted to the Commission for purposes of this Investigation may be disclosed to and used: (i) By the Commission, its employees and Offices, and contract personnel (a) for developing or maintaining the records of this or a related proceeding, or (b) in internal investigations, audits, reviews, and evaluations relating to the programs, personnel, and operations of the Commission including under 5 U.S.C. Appendix 3; or (ii) by U.S. government employees and contract personnel,\1\ solely for cybersecurity purposes. All nonconfidential written submissions will be available for public inspection at the Office of the Secretary and on EDIS. --------------------------------------------------------------------------- \1\ All contract personnel will sign appropriate nondisclosure agreements. --------------------------------------------------------------------------- The authority for the Commission's determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in Part 210 of the Commission's Rules of [[Page 48867]] --------------------------------------------------------------------------- Practice and Procedure (19 CFR part 210). By order of the Commission. Issued: September 21, 2018. Lisa Barton, Secretary to the Commission. [FR Doc. 2018-21007 Filed 9-26-18; 8:45 am] BILLING CODE 7020-02-P
![Federal Register / Vol. 83, No. 188 / Thursday, September 27, 2018 / Notices 48865
to the programs, personnel, and investigation are or will be available for On July 23, 2018, the ALJ issued the
operations of the Commission including inspection during official business final ID. The ID finds, inter alia, that
under 5 U.S.C. Appendix 3; or (ii) by hours (8:45 a.m. to 5:15 p.m.) in the Ivoclar failed to demonstrate
U.S. government employees and Office of the Secretary, U.S. infringement of the above-referenced
contract personnel, solely for International Trade Commission, 500 E claims of the ’836 patent. The ID finds,
cybersecurity purposes. All contract Street SW, Washington, DC 20436, inter alia, that claims 36 and 38 (‘‘the
personnel will sign appropriate telephone (202) 205–2000. General ’894 flexure strength claims’’) are
nondisclosure agreements. information concerning the Commission invalid as indefinite under 35 U.S.C.
Authority: These investigations are may also be obtained by accessing its 112 ¶ 2. The ID further finds that Ivoclar
being conducted under authority of title internet server at https://www.usitc.gov. failed to demonstrate infringement and
VII of the Tariff Act of 1930; this notice The public record for this investigation failed to meet the technical prong of the
is published pursuant to section 207.12 may be viewed on the Commission’s domestic industry requirement as to the
of the Commission’s rules. electronic docket (EDIS) at https:// remaining claims of the ’894 patent
By order of the Commission. edis.usitc.gov. Hearing-impaired (claims 1, 2, 4, 5, 7, 9, 10, 13, 15–19, and
Issued: September 21, 2018. persons are advised that information on 21) (‘‘the ’894 annealing claims’’). The
this matter can be obtained by ID finds that some, but not all, of the
Lisa Barton,
contacting the Commission TDD ’894 annealing claims are invalid in
Secretary to the Commission.
terminal on (202) 205–1810. view of certain prior art.
[FR Doc. 2018–20990 Filed 9–26–18; 8:45 am] Ivoclar, GC, and the Commission
BILLING CODE 7020–02–P SUPPLEMENTARY INFORMATION: The investigative attorney filed petitions for
Commission instituted this investigation review and replies to the other parties’
on April 25, 2017, based on a complaint, petitions.
INTERNATIONAL TRADE as supplemented, filed by Ivoclar Having reviewed the record of the
COMMISSION Vivadent AG of Schaan, Liechtenstein; investigation, including the final ID, as
[Investigation No. 337–TA–1050] Ivoclar Vivadent, Inc. of Amherst, New well as the parties’ petitions for review
York; and Ardent, Inc. of Amherst, New and responses thereto, the Commission
Certain Dental Ceramics, Products York (collectively ‘‘Ivoclar’’). 82 FR has determined as follows. The
Thereof, and Methods of Making the 19081 (Apr. 25, 2017). The complaint, Commission has determined to review
Same; Commission Decision To as supplemented, alleged violations of the ID’s findings as to the ’894 annealing
Review in Part a Final Initial section 337 of the Tariff Act of 1930, as claims. The Commission has
Determination Finding No Violation of amended (19 U.S.C. 1337), in the determined not to review the ID’s
Section 337; Schedule for Filing importation into the United States, the findings as to the ’894 flexure strength
Written Submissions on the Issues sale for importation, or the sale within claims because the Commission finds
Under Review and on Remedy, the the United States after importation of that the invalidity of claims 36 and 38
Public Interest, and Bonding; certain dental ceramics, products has been shown clearly and
Extension of the Target Date thereof, and methods of making the convincingly. The Commission has
same by reason of the infringement of determined not to review the ID’s
AGENCY: U.S. International Trade findings for the ’836 patent claims.
Commission. certain claims of four United States
patents: U.S. Patent No. 7,452,836 (‘‘the Accordingly, the Commission finds no
ACTION: Notice. violation of section 337 as to the ’836
’836 patent’’); U.S. Patent No. 6,517,623
SUMMARY: Notice is hereby given that (‘‘the ’623 patent’’); U.S. Patent No. patent and as to the ’894 flexure
the U.S. International Trade 6,802,894 (‘‘the ’894 patent’’); and U.S. strength claims. The Commission has
Commission has determined to review Patent No. 6,455,451 (‘‘the ’451 patent’’). determined not to review the remainder
in part the final initial determination The notice of investigation named as of the ID.
In connection with the Commission’s
(‘‘final ID’’) issued by the presiding respondents GC Corporation of Tokyo,
review, the Commission notes that
administrative law judge (‘‘ALJ’’) on Japan; and GC America, Inc. of Alsip,
‘‘[a]ny issue not raised in a petition for
July 23, 2018, finding no violation of Illinois (collectively, ‘‘GC’’). The Office
review will be deemed to have been
section 337 of the Tariff Act of 1930, in of Unfair Import Investigations was also
abandoned by the petitioning party and
the above-captioned investigation. The named as a party.
may be disregarded by the Commission
Commission requests certain briefing The investigation was previously in reviewing the initial determination.’’
from the parties on the issues under terminated as to certain asserted patent 19 CFR 210.43(b)(2).
review, as indicated in this notice. The claims, including all of the asserted The parties are asked to provide
Commission also requests briefing from claims of the ’623 patent and the ’451 additional briefing on the following
the parties, interested persons, and patent, based upon withdrawal of the issues, with reference to the applicable
interested government agencies on the complaint. Order No. 18 (Nov. 21, law and the existing evidentiary record.
issues of remedy, the public interest, 2017), not reviewed, Notice (Dec. 6, For each argument presented, the
and bonding. The Commission has 2017); Order No. 24 (Dec. 19, 2017), not parties’ submissions should set forth
determined to extend the target date for reviewed, Notice (Jan. 18, 2018); Order whether and/or how that argument was
completion of the investigation from No. 51 (Feb. 22, 2018), not reviewed, presented and preserved in the
November 23, 2018 to November 30, Notice (Mar. 23, 2018); Order No. 56 proceedings before the ALJ, in
2018. (Mar. 28, 2018), not reviewed, Notice conformity with the ALJ’s Ground Rules
daltland on DSKBBV9HB2PROD with NOTICES
FOR FURTHER INFORMATION CONTACT: (Apr. 27, 2018). Remaining within the (Order No. 2), with citations to the
Sidney A. Rosenzweig, Office of the scope of the investigation, as to record.
General Counsel, U.S. International infringement, domestic industry, or 1. For purposes of invalidity of the
Trade Commission, 500 E Street SW, both, are claims 1, 2, 4, 5, 7, 9, 10, 13, ’894 annealing claims, if the
Washington, DC 20436, telephone (202) 15–19, and 21 of the ’836 patent; and Commission were to find that a person
708–2532. Copies of non-confidential claims 1, 2, 4, 16–21, 34, 36 and 38 of of ordinary skill is entitled to rely upon
documents filed in connection with this the ’894 patent. the patentee’s representation about the
VerDate Sep<11>2014 17:20 Sep 26, 2018 Jkt 244001 PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 E:\FR\FM\27SEN1.SGM 27SEN1](https://thefederalregister.org/doc/83_FR_49053/page/1.svg)
![Federal Register / Vol. 83, No. 188 / Thursday, September 27, 2018 / Notices 48867
Practice and Procedure (19 CFR part may satisfy the knowledge requirement members affiliated with any one
210). through the successful completion of actuarial organization or employed with
By order of the Commission. Joint Board examinations in basic any one firm.
Issued: September 21, 2018.
actuarial mathematics and methodology Membership normally will be limited
and in actuarial mathematics and to actuaries currently enrolled by the
Lisa Barton,
methodology relating to pension plans Joint Board. However, individuals
Secretary to the Commission. qualifying under ERISA. having academic or other special
[FR Doc. 2018–21007 Filed 9–26–18; 8:45 am] The Joint Board, the Society of qualifications of particular value for the
BILLING CODE 7020–02–P Actuaries, and the American Society of Advisory Committee’s work will also be
Pension Professionals & Actuaries considered for membership. Federally-
jointly offer examinations acceptable to registered lobbyists and individuals
JOINT BOARD FOR THE the Joint Board for enrollment purposes affiliated with Joint Board enrollment
ENROLLMENT OF ACTUARIES and which are acceptable to the other examination preparation courses are not
two actuarial organizations as part of eligible to serve on the Advisory
Invitation for Membership on Advisory their respective examination programs Committee.
Committee
2. Scope of Advisory Committee Duties 5. Member Designation
AGENCY: Joint Board for the Enrollment The Advisory Committee plays an Advisory Committee members are
of Actuaries. integral role in the examination program appointed as Special Government
ACTION: Request for applications. by assisting the Joint Board in offering Employees (SGEs). As such, members
examinations that enable examination are subject to certain ethical standards
SUMMARY: The Joint Board for the candidates to demonstrate the
Enrollment of Actuaries (Joint Board), applicable to SGEs. Upon appointment,
knowledge necessary to qualify for each member will be required to
established under the Employee enrollment. The Advisory Committee’s
Retirement Income Security Act of 1974 provide written confirmation that he/
duties, which are strictly advisory, she does not have a financial interest in
(ERISA), is responsible for the include (1) recommending topics for
enrollment of individuals who wish to a Joint Board examination preparation
inclusion on the Joint Board course. In addition, each member will
perform actuarial services under ERISA. examinations, (2) reviewing and drafting
To assist in its examination duties be required to attend annual ethics
examination questions, (3) training.
mandated by ERISA, the Joint Board recommending examinations, (4)
established the Advisory Committee on reviewing examination results and 6. Application Requirements
Actuarial Examinations (Advisory recommending passing scores, and (5) To receive consideration, an
Committee) in accordance with the providing other recommendations and individual interested in serving on the
provisions of the Federal Advisory advice relative to the examinations, as Advisory Committee must submit (1) a
Committee Act (FACA). The current requested by the Joint Board. signed, cover letter expressing interest
Advisory Committee members’ terms
3. Member Terms and Responsibilities in serving on the Advisory Committee
expire on February 28, 2019. This notice
and describing his/her professional
describes the Advisory Committee and Members are appointed for a 2-year qualifications, and (2) a resume and/or
invites applications from those term. The upcoming term will begin on curriculum vitae. Applications may be
interested in serving on the Advisory March 1, 2019, and end on February 28, submitted by regular mail, overnight
Committee for the March 1, 2019– 2021. Members may seek reappointment and express delivery services, and
February 28, 2021 term. for additional consecutive terms. email. In all cases, the cover letter must
DATES: Applications for membership on Members are expected to attend contain an original signature.
the Advisory Committee must be approximately 4 meetings each calendar Applications must be received by
received no later than December 7, year and are reimbursed for travel December 7, 2018.
2018. expenses in accordance with applicable
government regulations. In general, Dated: September 19, 2018.
ADDRESSES: You may mail or deliver Thomas V. Curtin, Jr.,
members are expected to devote 125 to
applications to: Internal Revenue Executive Director, Joint Board for the
175 hours, including meeting time, to
Service; Joint Board for the Enrollment Enrollment of Actuaries.
the work of the Advisory Committee
of Actuaries; SE:RPO, Room 3422/IR,
over the course of a year. [FR Doc. 2018–21001 Filed 9–26–18; 8:45 am]
Attn: Ms. Elizabeth Van Osten; 1111
BILLING CODE 4830–01–P
Constitution Avenue NW, Washington, 4. Member Selection
DC 20224. Applications may also be The Joint Board seeks to appoint an
sent electronically to: nhqjbea@irs.gov. Advisory Committee that is fairly
See SUPPLEMENTARY INFORMATION for balanced in terms of points of view DEPARTMENT OF JUSTICE
application requirements. represented and functions to be
FOR FURTHER INFORMATION CONTACT: performed. Every effort is made to Drug Enforcement Administration
Elizabeth Van Osten, Designated Federal ensure that most points of view extant
[Docket No. DEA–392]
Officer, at 202–317–3648. in the enrolled actuary profession are
SUPPLEMENTARY INFORMATION: represented on the Advisory Committee. Bulk Manufacturer of Controlled
To that end, the Joint Board seeks to Substances Application: Nanosyn, Inc.
daltland on DSKBBV9HB2PROD with NOTICES
1. Background appoint several members from each of
To qualify for enrollment to perform the main practice areas of the enrolled ACTION: Notice of application.
actuarial services under ERISA, an actuary profession, including small
applicant must satisfy certain employer plans, large employer plans, DATES: Registered bulk manufacturers of
experience and knowledge and multiemployer plans. In addition, the affected basic classes, and
requirements, which are set forth in the to ensure diversity of points of view, the applicants therefore, may file written
Joint Board’s regulations. An applicant Joint Board limits the number of comments on or objections to the
VerDate Sep<11>2014 17:20 Sep 26, 2018 Jkt 244001 PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 E:\FR\FM\27SEN1.SGM 27SEN1](https://thefederalregister.org/doc/83_FR_49053/page/3.svg)
Document Created: 2018-09-27 01:04:24
Document Modified: 2018-09-27 01:04:24
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Contact | Sidney A. Rosenzweig, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 708-2532. Copies of non- confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205-2000. General information concerning the Commission may also be obtained by accessing its internet server at https:// www.usitc.gov. The public record for this investigation may be viewed on the Commission's electronic docket (EDIS) at https://edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission TDD terminal on (202) 205- 1810. | |
| FR Citation | 83 FR 48865 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR